AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33932574 — intervention group
Group type: EXPERIMENTAL
Intervention: PHARM-DC intervention (pharmacist-directed transitional care including medication reconciliation, medication review, increased communication, patient education and counseling)
Number of subjects: 9776
Study 33932574 — intervention group
Group type: EXPERIMENTAL
Intervention: PHARM-DC intervention
Number of subjects: 9776
Study 35843488 — intervention group
Group type: EXPERIMENTAL
Intervention: Strabismus surgery
Number of subjects: 109
Study 35843488 — intervention group
Group type: COMPARATOR
Intervention: Contact lens care
Number of subjects: 109
Study 35843488 — intervention group
Group type: COMPARATOR
Intervention: Primary intraocular lens implantation
Number of subjects: 109
Study 35843488 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity in study eye
Number of subjects: 109
Study 34218277 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 10000
Study 34218277 — intervention group
Group type: COMPARATOR
Intervention: Particle Beam Therapy (PBT)
Number of subjects: 10000
Study 35929472 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401
Study 35929472 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4401
Study 32372296 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental rotation training (experimental group)
Number of subjects: 36
Study 32372296 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 36
Study 33111932 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (Si) at rates of 0, 4.0, 8.0, and 16 g L‐1 under three soil water conditions (50% and 100% of soil water retention capacity and complete submergence in a water blade of 5.0 cm)
Number of subjects: 0
Study 33111932 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (Si) at higher rates
Number of subjects: 0
Study 36035633 — intervention group
Group type: EXPERIMENTAL
Intervention: Iranian regimen including Ficus carica, Vitis vinifera, Safflower, Cicer arietinum, Descurainia sophia seeds, Ziziphus jujuba, chicken soup, barley soup, rose water, saffron, and cinnamon spices
Number of subjects: 160
Study 36035633 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 32241356 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom cantilever appliance producing 100 g of force for buccal translation
Number of subjects: 7
Study 32241356 — intervention group
Group type: COMPARATOR
Intervention: Control group (no appliance)
Number of subjects: 7
Study 34224268 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy and FIT
Number of subjects: 0
Study 34224268 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy alone
Number of subjects: 0
Study 35475308 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 μg/kg eptacog beta initial dose regimen (IDR)
Number of subjects: 25
Study 35475308 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 μg/kg eptacog beta initial dose regimen (IDR)
Number of subjects: 25
Study 33506907 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated puncture (research group)
Number of subjects: 120
Study 33506907 — intervention group
Group type: COMPARATOR
Intervention: Control group (no simulated puncture)
Number of subjects: 120
Study 35684022 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Diet
Number of subjects: 155
Study 35684022 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)-high meal frequency
Number of subjects: 155
Study 35684022 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)-physical activity
Number of subjects: 155
Study 33142014 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 170 mg once daily for 28 days
Number of subjects: 34
Study 33142014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 36206275 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of posterior pituitary bright spot (PPBS) in patients with CNS tuberculosis
Number of subjects: 100
Study 36206275 — intervention group
Group type: COMPARATOR
Intervention: Normal MRI brain (control group)
Number of subjects: 100
Study 34482587 — intervention group
Group type: EXPERIMENTAL
Intervention: PRF group
Number of subjects: 40
Study 34482587 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34482587 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study 32151752 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (BA) to exercise alone (minimal treatment control condition)
Number of subjects: 240
Study 32151752 — intervention group
Group type: EXPERIMENTAL
Intervention: BA + supervised and home-based exercise (SHE) + health education (HE)
Number of subjects: 240
Study 32151752 — intervention group
Group type: EXPERIMENTAL
Intervention: BA + SHE + cognitive-behavioral sessions focused on increasing and maintaining exercise (CBEX)
Number of subjects: 240
Study 32151752 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (BA, SHE, CBEX)
Number of subjects: 240
Study 34245094 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-supervised exercise
Number of subjects: 1146
Study 34245094 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-supported exercise
Number of subjects: 1146
Study 34245094 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1146
Study 32147068 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender scent (n = 40)
Number of subjects: 120
Study 32147068 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible glucose 30% (2 ml, n = 40)
Number of subjects: 120
Study 32147068 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention, n = 40)
Number of subjects: 120
Study 32147068 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 35776030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-Propofol
Number of subjects: 60
Study 35776030 — intervention group
Group type: COMPARATOR
Intervention: Ketamine-Midazolam
Number of subjects: 60
Study 32674651 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beat audio created with DMSPS algorithm
Number of subjects: 60
Study 32674651 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal music
Number of subjects: 60
Study 32674651 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 60
Study 35197167 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TB diagnosis
Number of subjects: 2160
Study 35197167 — intervention group
Group type: EXPERIMENTAL
Intervention: No TB diagnosis
Number of subjects: 2160
Study 35197167 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive with active TB
Number of subjects: 2160
Study 32306485 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 56
Study 32306485 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 56
Study 32306485 — intervention group
Group type: EXPERIMENTAL
Intervention: PE plus sertraline
Number of subjects: 56
Study 32306485 — intervention group
Group type: COMPARATOR
Intervention: Combat-exposed controls (CCs)
Number of subjects: 56
Study 35276995 — intervention group
Group type: EXPERIMENTAL
Intervention: VASpaper
Number of subjects: 17
Study 35276995 — intervention group
Group type: EXPERIMENTAL
Intervention: VASimages
Number of subjects: 17
Study 35276995 — intervention group
Group type: EXPERIMENTAL
Intervention: VASno-images
Number of subjects: 17
Study 33326140 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of erythrocyte concentrates
Number of subjects: 30
Study 33326140 — intervention group
Group type: COMPARATOR
Intervention: Athlete Biological Passport
Number of subjects: 30
Study 33103385 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis ssp. lactis B94 (15 billion)
Number of subjects: 25
Study 33103385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 34228019 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder Engagement Survey (developed by PCORI)
Number of subjects: 18
Study 32350172 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate carbohydrate-restricted diet (targeting 50% of calories) for 6 months
Number of subjects: 19
Study 32350172 — intervention group
Group type: COMPARATOR
Intervention: Conventional calorie-restricted diet using the food exchange table
Number of subjects: 19
Study 34635569 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0
Study 34635569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34635569 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib (after accounting for crossover)
Number of subjects: 0
Study 35298833 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel 2% (5 g/daily) for 24 weeks
Number of subjects: 120
Study 35298833 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 120
Study 35167505 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm tourniquet
Number of subjects: 40
Study 35167505 — intervention group
Group type: COMPARATOR
Intervention: Upper arm tourniquet
Number of subjects: 40
Study 34106922 — intervention group
Group type: EXPERIMENTAL
Intervention: Levo-Praziquantel (L-PZQ) ODT 150 mg
Number of subjects: 48
Study 34106922 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemate Praziquantel (Rac-PZQ) ODT 150 mg
Number of subjects: 48
Study 34106922 — intervention group
Group type: COMPARATOR
Intervention: PZQ 600 mg formulation (PZQ-Cesol) crushed and dispersed in water
Number of subjects: 48
Study 33309783 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifidus activating exercise
Number of subjects: 241
Study 34446332 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT), performed once a week for 12 weeks on quadriceps femoris muscles.
Number of subjects: 18
Study 33731734 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual skills development course (study group)
Number of subjects: 30
Study 33731734 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 32318831 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated microbrush (MB)
Number of subjects: 60
Study 32318831 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated microbrush + air polishing (MB + air polishing)
Number of subjects: 60
Study 32318831 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrubbing with an ethanol‐saturated cotton pellet (CP)
Number of subjects: 60
Study 32318831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning with a round bur
Number of subjects: 60
Study 32318831 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing alone (ProphyFlex, KaVo)
Number of subjects: 60
Study 32318831 — intervention group
Group type: COMPARATOR
Intervention: Air/water spray (control group)
Number of subjects: 60
Study 34229861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg.kg-1 bolus over 3 minutes, followed by continuous infusion at 2 mg.kg-1.h-1)
Number of subjects: 85
Study 34229861 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline solution (control group)
Number of subjects: 85
Study 32925634 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective induction of labor
Number of subjects: 4661
Study 32925634 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 4661
Study 33199054 — intervention group
Group type: EXPERIMENTAL
Intervention: Online mental health screening tool
Number of subjects: 126060
Study 33199054 — intervention group
Group type: EXPERIMENTAL
Intervention: Online mental health screening tool with in-person care referral
Number of subjects: 126060
Study 34564685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-alveolar administration of dexamethasone 4 mg
Number of subjects: 0
Study 34564685 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of dexamethasone
Number of subjects: 0
Study 32035662 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-times/week static stretching (2 min of SS thrice per week)
Number of subjects: 24
Study 32035662 — intervention group
Group type: COMPARATOR
Intervention: One-time/week static stretching (6 min of SS once per week)
Number of subjects: 24
Study 35743552 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT‐SS
Number of subjects: 40
Study 35743552 — intervention group
Group type: COMPARATOR
Intervention: PCT
Number of subjects: 40
Study 36227615 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine (1000 mg/m2 twice daily for 14 days every 3 weeks for 8 cycles)
Number of subjects: 180
Study 36227615 — intervention group
Group type: COMPARATOR
Intervention: Observation following CCRT (100 mg/m2 cisplatin every 3 weeks for 2 to 3 cycles)
Number of subjects: 180
Study 36227615 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 180
Study 36227615 — intervention group
Group type: COMPARATOR
Intervention: Control (Observation)
Number of subjects: 180
Study 34029648 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 20 min)
Number of subjects: 20
Study 34029648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA for 20 min)
Number of subjects: 20
Study 34029648 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (2 mA for 20 min)
Number of subjects: 20
Study 36103060 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NAC)
Number of subjects: 212
Study 36103060 — intervention group
Group type: EXPERIMENTAL
Intervention: D2-gastrectomy
Number of subjects: 212
Study 34525837 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 left ventricular assist device (HM 3)
Number of subjects: 1015
Study 33180001 — intervention group
Group type: EXPERIMENTAL
Intervention: spiritually‐integrated cognitive‐behavioral educational group intervention
Number of subjects: 84
Study 32057811 — intervention group
Group type: EXPERIMENTAL
Intervention: MiFusion TLS2 system (Endotrust, Nettetal Germany)
Number of subjects: 100
Study 32057811 — intervention group
Group type: COMPARATOR
Intervention: LigaSure Maryland system (Medtronic, Dublin, Ireland)
Number of subjects: 100
Study 35366853 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 60 μg/day and aspirin 100 mg/day
Number of subjects: 64
Study 35366853 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg/day
Number of subjects: 64
Study 34453114 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised behavioural advice facilitated by a trained lay advisor
Number of subjects: 234
Study 34453114 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 234
Study 32128614 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated high TENS (IMT)
Number of subjects: 20
Study 32128614 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS (PBT)
Number of subjects: 20
Study 32128614 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IMT and PBT
Number of subjects: 20
Study 36078303 — intervention group
Group type: EXPERIMENTAL
Intervention: Built-shade PRAs
Number of subjects: 1144
Study 36078303 — intervention group
Group type: COMPARATOR
Intervention: Control PRAs (unshaded)
Number of subjects: 1144
Study 34776874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar intermittent theta-burst stimulation (iTBS)
Number of subjects: 32
Study 34776874 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study 34533102 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) twice-weekly for 10 weeks
Number of subjects: 12
Study 34533102 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 12
Study 34533102 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 12
Study 32988892 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally access spine surgery (MASS)
Number of subjects: 49
Study 32988892 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 49
Study 34264739 — intervention group
Group type: EXPERIMENTAL
Intervention: Percent of negative urinalysis
Number of subjects: 441
Study 34264739 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomous outcome measures
Number of subjects: 441
Study 35613802 — intervention group
Group type: EXPERIMENTAL
Intervention: JTR-161 (allogeneic human dental pulp stem cells)
Number of subjects: 76
Study 35613802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 33426790 — intervention group
Group type: EXPERIMENTAL
Intervention: YOTES (Youth Online Training and Employment System) - a moderated, online intervention with vocational, social, and peer motivation
Number of subjects: 0
Study 33426790 — intervention group
Group type: COMPARATOR
Intervention: Control intervention - headspace Digital Work and Study Service
Number of subjects: 0
Study 33426790 — intervention group
Group type: EXPERIMENTAL
Intervention: YOTES
Number of subjects: 0
Study 32963065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OACs)
Number of subjects: 0
Study 35677972 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin aerosol (50 mg/ml, 10 ml total volume)
Number of subjects: 32
Study 35677972 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin aerosol (50 mg/ml, 20 ml total volume)
Number of subjects: 32
Study 35677972 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin aerosol (100 mg/ml, 10 ml total volume)
Number of subjects: 32
Study 35677972 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin aerosol (100 mg/ml, 20 ml total volume)
Number of subjects: 32
Study 35677972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34447320 — intervention group
Group type: EXPERIMENTAL
Intervention: VR relaxation
Number of subjects: 74
Study 34447320 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 74
Study 35834302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-assisted mHealth (WeChat) intervention based on the Integrated Theory of Health Behavior Change (ITHBC) for TB management
Number of subjects: 114
Study 35834302 — intervention group
Group type: COMPARATOR
Intervention: Routine medical and nursing care in the TB clinic (Control group)
Number of subjects: 114
Study 34535979 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention with four daily short text messages for 30 days
Number of subjects: 0
Study 34535979 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 34535979 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention
Number of subjects: 0
Study 34984851 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 20
Study 34984851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Number of subjects: 20
Study 34665055 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive heating with three different heaters (compressed-air blower heater, intravenous fluid heating, heating bed)
Number of subjects: 39
Study 34665055 — intervention group
Group type: COMPARATOR
Intervention: Standard compressed-air blower heater
Number of subjects: 39
Study 34665055 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive heating
Number of subjects: 39
Study 34632798 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fat ingestion
Number of subjects: 40
Study 35674747 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose triple combination therapy
Number of subjects: 0
Study 35674747 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34127756 — intervention group
Group type: EXPERIMENTAL
Intervention: Updated Swedish reference ranges for estimated fetal weight (EFW) using Hadlock's 3rd formula from gestational week 12 to 42.
Number of subjects: 583
Study 34187547 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversation-based decision aid (Option Grid) containing cost information about slow-growing prostate cancer management options, combined with urologic surgeon training
Number of subjects: 0
Study 34187547 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study 35977772 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology intervention (PPI) workshop covering four techniques: gratitude visits/letters, three good things, you at your best, using signature strengths; duration of 1.5 hours with a booster intervention at 1 week.
Number of subjects: 120
Study 35977772 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 120
Study 33097936 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (∼4 g/d)
Number of subjects: 0
Study 33097936 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA supplementation (∼4 g/d)
Number of subjects: 0
Study 32357322 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 2634
Study 32357322 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 2634
Study 32357322 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 2634
Study 36115558 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCS-guided PDT
Number of subjects: 39
Study 36115558 — intervention group
Group type: COMPARATOR
Intervention: PTCD
Number of subjects: 39
Study 35636772 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist supported online remote behavioural intervention for tics
Number of subjects: 0
Study 35636772 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33504211 — intervention group
Group type: EXPERIMENTAL
Intervention: PPD
Number of subjects: 150
Study 33504211 — intervention group
Group type: EXPERIMENTAL
Intervention: Candida antigen
Number of subjects: 150
Study 33504211 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine
Number of subjects: 150
Study 32029008 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion
Number of subjects: 100
Study 32029008 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen sustained-release capsules
Number of subjects: 100
Study 35576498 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Syllable Transition Treatment (ReST)
Number of subjects: 4